Diagnosing lung cancer: is the 28 day rule appropriate?

M. Al-Aloul, C. Smyth, M. Ledson, M. Walshaw (Liverpool, United Kingdom)

Source: Annual Congress 2004 - Diagnostic management of lung cancer, clinical features
Session: Diagnostic management of lung cancer, clinical features
Session type: Thematic Poster Session
Number: 1917
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Al-Aloul, C. Smyth, M. Ledson, M. Walshaw (Liverpool, United Kingdom). Diagnosing lung cancer: is the 28 day rule appropriate?. Eur Respir J 2004; 24: Suppl. 48, 1917

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Monitoring of early lung disease: Is it clinically important to do routine infant lung function test?
Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early
Year: 2004

Novel aspects in lung cancer pathology: how does it help for selecting chemotherapy?
Source: Annual Congress 2010 - PG4 Core Curriculum Postgraduate Course: Pathology for the clinician
Year: 2010



Pulmonary function in elderly patients with diagnosis of lung cancer – an excuse for giving up surgery?
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008


In whom could we diagnose second primary lung cancers ‘early’?
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019

Treatment of early lung disease – is it possible? Does it work?
Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early
Year: 2004

Clinical course of asymptomatic small enhancing brain nodules in patients with nonsmall cell lung cancer: do we have to follow them up?
Source: ERJ Open Res, 6 (3) 00109-2020; 10.1183/23120541.00109-2020
Year: 2020



ALK- and ROS-1-inhibition: a relevant treatment strategy for lung cancer?
Source: International Congress 2014 – Update on lung cancer biology for clinicians
Year: 2014



Shall we disclose the diagnosis of lung cancer to the patient?
Source: Eur Respir J 2006; 28: Suppl. 50, 40s
Year: 2006

Management of incidental nodules in lung cancer screening: ready for prime-time?
Source: Breathe, 15 (4) 346; 10.1183/20734735.0247-2019
Year: 2019



Granulomatous reaction in a patient with lung cancer: should we treat it?
Source: Breathe, 14 (3) e94; 10.1183/20734735.014617
Year: 2018



An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006

Why can initial treatment of localised lung cancer fail?
Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent
Year: 2007


Surgery for non small cell lung cancer (NSCLC) and functional limits: is there a possible beneficial role of preoperative pulmonary rehabilitation?
Source: Eur Respir J 2004; 24: Suppl. 48, 522s
Year: 2004

How do lung cancer patients die?
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Is time from "referral to diagnosis" in lung cancer pathway affected by diagnostic test delays?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015

Screening for lung cancer: who should (not) be enrolled?
Source: International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?
Year: 2019


Monitoring of early lung disease. To know is to treat!
Source: Annual Congress 2004 - PG19 - Screening for cystic fibrosis: diagnose early - treat early
Year: 2004


ERS School Course Early-stage lung cancer - What's new in the epidemiology of lung cancer: the female aspect
Source: ISSN=ISSN 1810-6838, ISBN=, page=339
Year: 2006

Targeted therapies for lung cancer: how did the game begin?
Source: Breathe 2016; 12: 177-179
Year: 2016